Cargando…
In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism
Hypercoagulability is frequently observed in patients with severe coronavirus disease-2019 (COVID-19). Platelets are a favorable target for effectively treating hypercoagulability in COVID-19 patients as platelet hyperactivity has also been observed. It is difficult to develop a treatment for COVID-...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482091/ https://www.ncbi.nlm.nih.gov/pubmed/36160270 http://dx.doi.org/10.1016/j.jgr.2022.09.001 |